We have collected information about Receptor-Targeted Nanocarriers For Therapeutic Delivery To Cancer for you. Follow the links to find out details on Receptor-Targeted Nanocarriers For Therapeutic Delivery To Cancer.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789246/
As an alternative, receptor-targeted nanocarrier drug delivery system is an emerging platform in development of cancer therapy (Arap et al. 1998, Allen 2002, Sapra and Allen 2003, Noble et al. 2004, El Bayoumi and Torchilin 2009).Author: Bo Yu, Heng Chiat Tai, Weiming Xue, L. James Lee, Robert J. Lee
https://www.tandfonline.com/doi/pdf/10.3109/09687688.2010.521200
selective delivery to the tumour cell or the tumour vasculature. Indeed, receptor-targeted nanocarrier delivery has been shown to improve therapeutic responses both in vitro and in vivo. A variety of ligands have been investigated including folate,
https://www.tandfonline.com/doi/10.3109/09687688.2010.521200
AbstractEfficient and site-specific delivery of therapeutic drugs is a critical challenge in clinical treatment of cancer. Nano-sized carriers such as liposomes, micelles, and polymeric nanoparticl...Author: Bo Yu, Heng Chiat Tai, Weiming Xue, L. James Lee, Robert J. Lee
https://www.researchgate.net/publication/47620023_Receptor-targeted_nanocarriers_for_therapeutic_delivery_to_cancer
RNAi-based gene therapy has been recently considered as a promising approach against cancer. Targeted delivery of drug, gene or therapeutic RNAi-based systems to tumor cells is one of the ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607294/
In this regard, we review one of the most promising nanomedcine approaches in targeted cancer therapy, namely, the utilization of EGF receptor (EGFR) targeting to enhance delivery of therapeutic and diagnostic agents to EGFR-overexpressing cancers.Author: Alyssa M Master, Anirban Sen Gupta
https://www.sciencedirect.com/science/article/pii/B9780128140338000060
6.2. PEGylated Gelatin Nanocarriers: Targeted Drug Delivery for Cancer Therapy. PEGylation is a process through which polyethylene glycol (PEG) chains are conjugated to proteins (therapeutic proteins), peptides, or any molecule. Through the PEGylation process, the molecular mass of the therapeutic protein is increased.Author: Mahadevappa Y. Kariduraganavar, Geetha B. Heggannavar, Sandra Amado, Geoffrey R. Mitchell, Geoffrey ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751402/
Targeted pharmaceutical nanocarriers for cancer therapy and imaging. Department of Pharmaceutical Sciences and Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, 02115 Boston, MA. Vladimir P. Torchilin, Phone: (617) 373-3296, Fax: (617) 373-8886, Email: [email protected]: Vladimir P. Torchilin
Searching for Receptor-Targeted Nanocarriers For Therapeutic Delivery To Cancer?
You can just click the links above. The data is collected for you.
